Kir3.4

1

Sertedaki A et al. Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without Primary Aldosteronism but with ACTH-dependent aldosterone hypersecretion.
Clin. Endocrinol. (Oxf), 2016 Jun 13 , ().

2

Williams TA et al. Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas.
Hypertension, 2016 Jan , 67 (139-45).

3

Nishimoto K et al. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
J. Clin. Endocrinol. Metab., 2016 Jan , 101 (6-9).

4

Zhao Y et al. Regulation of SCN3B/scn3b by Interleukin 2 (IL-2): IL-2 modulates SCN3B/scn3b transcript expression and increases sodium current in myocardial cells.
BMC Cardiovasc Disord, 2016 , 16 (1).

5

Holmes AP et al. A Regional Reduction in Ito and IKACh in the Murine Posterior Left Atrial Myocardium Is Associated with Action Potential Prolongation and Increased Ectopic Activity.
PLoS ONE, 2016 , 11 (e0154077).

6

Touhara KK et al. The GIRK1 subunit potentiates G protein activation of cardiac GIRK1/4 hetero-tetramers.
Elife, 2016 , 5 ().

7

Bragança B et al. Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria.
Front Pharmacol, 2016 , 7 (45).

8

He F et al. Effect of small interference RNA on the acetylcholine-sensitive potassium channel in H9c2 cells.
Ann. Clin. Lab. Sci., 2015 Winter , 45 (58-63).

9

Kienitz MC et al. NCI-H295R cell line as in vitro model of hyperaldosteronism lacks functional KCNJ5 (GIRK4; Kir3.4) channels.
Mol. Cell. Endocrinol., 2015 Sep 5 , 412 (272-80).

10

Åkerström T et al. Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas.
Endocr. Relat. Cancer, 2015 Oct , 22 (735-44).

11

Bukiya AN et al. Cholesterol increases the open probability of cardiac KACh currents.
Biochim. Biophys. Acta, 2015 Oct , 1848 (2406-13).

12

Fernandes-Rosa FL et al. Different Somatic Mutations in Multinodular Adrenals With Aldosterone-Producing Adenoma.
Hypertension, 2015 Nov , 66 (1014-22).

13

Felizola SJ et al. Pre-B Lymphocyte Protein 3 (VPREB3) Expression in the Adrenal Cortex: Precedent for non-Immunological Roles in Normal and Neoplastic Human Tissues.
Endocr. Pathol., 2015 May , 26 (119-28).

14

Zheng FF et al. Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma.
Hypertension, 2015 Mar , 65 (622-8).

15

Thomson SJ et al. Identification of the Intracellular Na+ Sensor in Slo2.1 Potassium Channels.
J. Biol. Chem., 2015 Jun 5 , 290 (14528-35).

16

Fernandes-Rosa FL et al. Functional histopathological markers of aldosterone producing adenoma and somatic KCNJ5 mutations.
Mol. Cell. Endocrinol., 2015 Jun 15 , 408 (220-6).

17

Monticone S et al. 6C.03: A CASE OF SEVERE HYPERALDOSTERONISM CAUSED BY A DE NOVO KCNJ5 MUTATION.
J. Hypertens., 2015 Jun , 33 Suppl 1 (e79-80).

18

Duan K et al. Clinicopathologic Correlates of Primary Aldosteronism.
Arch. Pathol. Lab. Med., 2015 Jul , 139 (948-54).

19

Monticone S et al. A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue.
J. Clin. Endocrinol. Metab., 2015 Jan , 100 (E114-8).

20

Cheng CJ et al. Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
J. Clin. Endocrinol. Metab., 2015 Jan , 100 (E155-63).

21

Zhang J et al. [Sequence analysis of coding regions of KCNJ5 gene in unilateral adrenal hyperplasia].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2015 Feb , 32 (21-5).

22

Xiong WH et al. Voriconazole, an antifungal triazol that causes visual side effects, is an inhibitor of TRPM1 and TRPM3 channels.
Invest. Ophthalmol. Vis. Sci., 2015 Feb , 56 (1367-73).

23

Zennaro MC et al. An update on novel mechanisms of primary aldosteronism.
J. Endocrinol., 2015 Feb , 224 (R63-77).

24

Monticone S et al. Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas.
Mol. Cell. Endocrinol., 2015 Aug 15 , 411 (146-54).

25

Lenzini L et al. A Meta-Analysis of Somatic KCNJ5 K(+) Channel Mutations In 1636 Patients With an Aldosterone-Producing Adenoma.
J. Clin. Endocrinol. Metab., 2015 Aug , 100 (E1089-95).

26

Henn MC et al. Adenosine Triphosphate-Sensitive Potassium Channel Kir Subunits Implicated in Cardioprotection by Diazoxide.
J Am Heart Assoc, 2015 Aug , 4 (e002016).

27

Markou A et al. Stress-induced Aldosterone Hyper-Secretion in a Substantial Subset of Patients With Essential Hypertension.
J. Clin. Endocrinol. Metab., 2015 Aug , 100 (2857-64).

28

Lenzini L et al. The molecular basis of primary aldosteronism: from chimeric gene to channelopathy.
Curr Opin Pharmacol, 2015 Apr , 21 (35-42).

29

Wang B et al. Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients.
Medicine (Baltimore), 2015 Apr , 94 (e708).

30

Cannon SC Channelopathies of skeletal muscle excitability.
Compr Physiol, 2015 Apr , 5 (761-90).

31

Ip JC et al. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism.
ANZ J Surg, 2015 Apr , 85 (279-83).

32

Kitamoto T et al. Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas.
J. Atheroscler. Thromb., 2015 , 22 (191-200).

33

Allegue C et al. Genetic Analysis of Arrhythmogenic Diseases in the Era of NGS: The Complexity of Clinical Decision-Making in Brugada Syndrome.
PLoS ONE, 2015 , 10 (e0133037).

34

Wu VC et al. Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population.
Sci Rep, 2015 , 5 (11396).

35

Boulkroun S et al. Molecular and Cellular Mechanisms of Aldosterone Producing Adenoma Development.
Front Endocrinol (Lausanne), 2015 , 6 (95).

36

Kuppusamy M et al. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
J. Clin. Endocrinol. Metab., 2014 Sep , 99 (E1765-73).

37

Zhang H et al. [Progress on genetic basis of primary aldosteronism].
Zhejiang Da Xue Xue Bao Yi Xue Ban, 2014 Sep , 43 (612-8).

38

Felizola SJ et al. Voltage-gated calcium channels in the human adrenal and primary aldosteronism.
J. Steroid Biochem. Mol. Biol., 2014 Oct , 144 Pt B (410-6).

39

Ye G et al. Effects of Ca2+-activated potassium and inward rectifier potassium channel on the differentiation of endothelial progenitor cells from human peripheral blood.
Mol. Biol. Rep., 2014 May , 41 (3413-23).

40

Kokunai Y et al. A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1.
Neurology, 2014 Mar 25 , 82 (1058-64).

41

Kienitz MC et al. Differential effects of genetically-encoded Gβγ scavengers on receptor-activated and basal Kir3.1/Kir3.4 channel current in rat atrial myocytes.
Cell. Signal., 2014 Jun , 26 (1182-92).

42

Fischer E et al. Novel genes in primary aldosteronism.
Curr Opin Endocrinol Diabetes Obes, 2014 Jun , 21 (154-8).

43

Zhang H et al. Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy.
Anesthesiology, 2014 Jun , 120 (1463-75).

44

Tanwar V et al. Gremlin 2 promotes differentiation of embryonic stem cells to atrial fate by activation of the signaling pathway.
Stem Cells, 2014 Jul , 32 (1774-88).

45

Rossi GP et al. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
J. Hypertens., 2014 Jul , 32 (1514-21; discussion 1522).

46

Gómez L et al. Association of the KCNJ5 gene with Tourette Syndrome and Attention-Deficit/Hyperactivity Disorder.
Genes Brain Behav., 2014 Jul , 13 (535-42).

47

Zhang Y et al. Glycogen Synthase Kinase-3β Inhibition Ameliorates Cardiac Parasympathetic Dysfunction in Type 1 Diabetic Akita Mice.
Diabetes, 2014 Jan 23 , ().

48

Liang B et al. G-protein-coupled inward rectifier potassium current contributes to ventricular repolarization.
Cardiovasc. Res., 2014 Jan 1 , 101 (175-84).

49

Feldman RD Aldosterone and blood pressure regulation: recent milestones on the long and winding road from electrocortin to KCNJ5, GPER, and beyond.
Hypertension, 2014 Jan , 63 (19-21).

50

Gomez-Sanchez CE et al. Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy?
Endocrinology, 2014 Jan , 155 (47-55).

51

Li N et al. [Association of GIRK4 gene polymorphisms with essential hypertension in obese ethnics Uygur from southern Xinjiang].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2014 Feb , 31 (88-92).

52

Dutta RK et al. Complementary somatic mutations of KCNJ5, ATP1A1, and ATP2B3 in sporadic aldosterone producing adrenal adenomas.
Endocr. Relat. Cancer, 2014 Feb , 21 (L1-4).

53

Gomez-Sanchez CE et al. Somatic mutations of the ATP1A1 gene and aldosterone-producing adenomas.
Mol. Cell. Endocrinol., 2014 Dec 10 , ().

54

Fernandes-Rosa FL et al. Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma.
Hypertension, 2014 Aug , 64 (354-61).

55

Weeke P et al. Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome.
J. Am. Coll. Cardiol., 2014 Apr 15 , 63 (1430-7).

56

Li N et al. [Association of KCNJ5 gene rs3740835(C/A) and rs2604204(A/C) polymorphism with unilateral and bilateral primary aldosteronism].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2014 Apr , 31 (233-7).

57

Tauber P et al. Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas.
Endocrinology, 2014 Apr , 155 (1353-62).

58

Murthy M et al. Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
Hypertension, 2014 Apr , 63 (783-9).

59

Al-Salameh A et al. Overview of the genetic determinants of primary aldosteronism.
Appl Clin Genet, 2014 , 7 (67-79).

60

Adachi M et al. Discordant genotype-phenotype correlation in familial hyperaldosteronism type III with KCNJ5 gene mutation: a patient report and review of the literature.
Horm Res Paediatr, 2014 , 82 (138-42).

61

Kumar M et al. Focus on Kir7.1: physiology and channelopathy.
Channels (Austin), 2014 , 8 (488-95).

62

Sivagangabalan G et al. Regional ion channel gene expression heterogeneity and ventricular fibrillation dynamics in human hearts.
PLoS ONE, 2014 , 9 (e82179).

63

Funder JW Genetics of primary aldosteronism.
Front Horm Res, 2014 , 43 (70-8).

64

Mesirca P et al. Cardiac arrhythmia induced by genetic silencing of 'funny' (f) channels is rescued by GIRK4 inactivation.
Nat Commun, 2014 , 5 (4664).

65

Williams TA et al. Somatic ATP1A1, ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas.
Hypertension, 2013 Sep 30 , ().

66

Azizan EA et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension.
Nat. Genet., 2013 Sep , 45 (1055-60).

67

Scholl UI et al. Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism.
Nat. Genet., 2013 Sep , 45 (1050-4).

68

Wang F et al. The phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R).
Heart Rhythm, 2013 Oct , 10 (1500-6).

69

Oßwald A et al. Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients.
Eur. J. Endocrinol., 2013 Nov , 169 (657-63).

70

Monticone S et al. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
J. Clin. Endocrinol. Metab., 2013 Nov , 98 (E1861-5).

71

Boulkroun S et al. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling.
Mol. Cell. Endocrinol., 2013 May 22 , 371 (221-7).

72

Scholl UI et al. New insights into aldosterone-producing adenomas and hereditary aldosteronism: mutations in the K+ channel KCNJ5.
Curr. Opin. Nephrol. Hypertens., 2013 Mar , 22 (141-7).

73

Kaufmann K et al. ML297 (VU0456810), the First Potent and Selective Activator of the GIRK Potassium Channel, Displays Antiepileptic Properties in Mice.
ACS Chem Neurosci, 2013 Jun 13 , ().

74

Stowasser M Primary aldosteronism and potassium channel mutations.
Curr Opin Endocrinol Diabetes Obes, 2013 Jun , 20 (170-9).

75

Kiss T et al. Identification of diterpene alkaloids from Aconitum napellus subsp. firmum and GIRK channel activities of some Aconitum alkaloids.
Fitoterapia, 2013 Jul 19 , ().

76

Ravens U et al. Atrial selectivity of antiarrhythmic drugs.
J. Physiol. (Lond.), 2013 Jul 16 , ().

77

Mesirca P et al. The G-protein-gated K+ channel, IKACh, is required for regulation of pacemaker activity and recovery of resting heart rate after sympathetic stimulation.
J. Gen. Physiol., 2013 Jul 15 , ().

78

Zennaro MC et al. Genetics of mineralocorticoid excess: an update for clinicians.
Eur. J. Endocrinol., 2013 Jul , 169 (R15-25).

79

Mulatero P et al. Role of KCNJ5 in familial and sporadic primary aldosteronism.
Nat Rev Endocrinol, 2013 Feb , 9 (104-12).

80

Kang YA et al. [Expression of GIRK4 gene in kidney tissues of obese rat].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2013 Feb , 35 (36-9).

81

Bingen BO et al. Atrium-specific Kir3.x determines inducibility, dynamics, and termination of fibrillation by regulating restitution-driven alternans.
Circulation, 2013 Dec 24 , 128 (2732-44).

82

Shao D et al. [Relationship between the G protein gated inward rectifier potassium channel 4 gene polymorphism and dyslipidemia of Uyghur residents].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2013 Dec , 35 (611-7).

83

Velarde-Miranda C et al. Regulation of aldosterone biosynthesis by the Kir3.4 (KCNJ5) potassium channel.
Clin. Exp. Pharmacol. Physiol., 2013 Dec , 40 (895-901).

84

Mahajan R et al. A computational model predicts that Gβγ acts at a cleft between channel subunits to activate GIRK1 channels.
Sci Signal, 2013 Aug 13 , 6 (ra69).

85

Arnesen T et al. Outcome after surgery for primary hyperaldosteronism may depend on KCNJ5 tumor mutation status: a population-based study from Western Norway.
Langenbecks Arch Surg, 2013 Aug , 398 (869-74).

86

Treiber F et al. Molecular basis of the facilitation of the heterooligomeric GIRK1/GIRK4 complex by cAMP dependent protein kinase.
Biochim. Biophys. Acta, 2013 Apr , 1828 (1214-21).

87

Li NF et al. Genetic variations in the KCNJ5 gene in primary aldosteronism patients from Xinjiang, China.
PLoS ONE, 2013 , 8 (e54051).

88

Atkinson AJ et al. Functional, anatomical, and molecular investigation of the cardiac conduction system and arrhythmogenic atrioventricular ring tissue in the rat heart.
J Am Heart Assoc, 2013 , 2 (e000246).

89

Molina-Navarro MM et al. Differential gene expression of cardiac ion channels in human dilated cardiomyopathy.
PLoS ONE, 2013 , 8 (e79792).

90

Holmegard HN et al. Genetic variation in the parasympathetic signaling pathway in patients with reflex syncope.
Genet. Mol. Res., 2013 , 12 (2601-10).

91

Oki K et al. The potassium channel, Kir3.4 participates in angiotensin II-stimulated aldosterone production by a human adrenocortical cell line.
Endocrinology, 2012 Sep , 153 (4328-35).

92

Charmandari E et al. A Novel Point Mutation in the KCNJ5 Gene Causing Primary Hyperaldosteronism and Early-Onset Autosomal Dominant Hypertension.
, 2012 May 24 , ().

93

Azizan EA et al. Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors.
J. Clin. Endocrinol. Metab., 2012 May , 97 (E819-29).

94

Kloukina V et al. G-protein-gated inwardly rectifying K+ channel 4 (GIRK4) immunoreactivity in chemically defined neurons of the hypothalamic arcuate nucleus that control body weight.
J. Chem. Neuroanat., 2012 May , 44 (14-23).

95

Boulkroun S et al. Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism.
Hypertension, 2012 Mar , 59 (592-8).

96

Azizan EA et al. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas.
Hypertension, 2012 Mar , 59 (587-91).

97

Mussa A et al. Polyuric-polydipsic syndrome in a pediatric case of non-glucocorticoid remediable familial hyperaldosteronism.
Endocr. J., 2012 Jun 30 , 59 (497-502).

98

Murthy M et al. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma.
, 2012 Jun 29 , ().

99

Bar-Lev A et al. Genetics of adrenocortical disease: an update.
Curr Opin Endocrinol Diabetes Obes, 2012 Jun , 19 (159-67).

100

Xekouki P et al. KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome.
Endocr. Relat. Cancer, 2012 Jun , 19 (255-60).

101

Li N et al. Influence of age on the association of GIRK4 with metabolic syndrome.
Ann. Clin. Biochem., 2012 Jul , 49 (369-76).

102

Scholl UI et al. Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5.
Proc. Natl. Acad. Sci. U.S.A., 2012 Feb 14 , 109 (2533-8).

103

Deng W et al. Hypercholesterolemia induces up-regulation of KACh cardiac currents via a mechanism independent of phosphatidylinositol 4,5-bisphosphate and Gβγ.
J. Biol. Chem., 2012 Feb 10 , 287 (4925-35).

104

Gomez-Sanchez CE et al. Mutations of the potassium channel KCNJ5 causing aldosterone-producing adenomas: one or two hits?
Hypertension, 2012 Feb , 59 (196-7).

105

Mulatero P et al. KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism.
Hypertension, 2012 Feb , 59 (235-40).

106

Li NF et al. [Association between GIRK4 gene polymorphisms and insulin resistance in Xinjiang Uygur population].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2012 Dec , 29 (715-9).

107

Seccia TM et al. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
J. Clin. Endocrinol. Metab., 2012 Dec , 97 (E2307-13).

108

Yamada M et al. KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas.
Endocr. J., 2012 Aug 31 , 59 (735-41).

109

Kang YA et al. Advances in research on G protein-coupled inward rectifier K(+) channel gene.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2012 Aug , 34 (426-30).

110

Monticone S et al. Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells.
J. Clin. Endocrinol. Metab., 2012 Aug , 97 (E1567-72).

111

Taguchi R et al. Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas.
J. Clin. Endocrinol. Metab., 2012 Apr , 97 (1311-9).

112

Oki K et al. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis.
Endocrinology, 2012 Apr , 153 (1774-82).

113

Funder JW The genetic basis of primary aldosteronism.
Curr. Hypertens. Rep., 2012 Apr , 14 (120-4).

114

Wu J et al. Regulatory mechanisms underlying the modulation of GIRK1/GIRK4 heteromeric channels by P2Y receptors.
Pflugers Arch., 2012 Apr , 463 (625-33).

115

Williams TA et al. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.
Hypertension, 2012 Apr , 59 (833-9).

116

Whorton MR et al. Crystal structure of the mammalian GIRK2 K+ channel and gating regulation by G proteins, PIP2, and sodium.
Cell, 2011 Sep 30 , 147 (199-208).

117

Chopra N et al. Genetics of sudden cardiac death syndromes.
, 2011 Mar 22 , ().

118

Zennaro MC et al. Mutations in KCNJ5 gene cause hyperaldosteronism.
Circ. Res., 2011 Jun 10 , 108 (1417-8).

119

Choi M et al. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
Science, 2011 Feb 11 , 331 (768-72).

120

Jabbari J et al. Common polymorphisms in KCNJ5 [corrected] are associated with early-onset lone atrial fibrillation in Caucasians.
Cardiology, 2011 , 118 (116-20).

121

Kobayashi T et al. Inhibition of g protein-activated inwardly rectifying k channels by different classes of antidepressants.
PLoS ONE, 2011 , 6 (e28208).

122

Voigt N et al. Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation.
Circ Arrhythm Electrophysiol, 2010 Oct 1 , 3 (472-80).

123

Yang Y et al. Identification of a Kir3.4 mutation in congenital long QT syndrome.
Am. J. Hum. Genet., 2010 Jun 11 , 86 (872-80).

124

Wagner V et al. Cloning and characterisation of GIRK1 variants resulting from alternative RNA editing of the KCNJ3 gene transcript in a human breast cancer cell line.
J. Cell. Biochem., 2010 Jun 1 , 110 (598-608).

125

Nobles M et al. HL-1 cells express an inwardly rectifying K+ current activated via muscarinic receptors comparable to that in mouse atrial myocytes.
Pflugers Arch., 2010 Jun , 460 (99-108).

126

Kobayashi T et al. Inhibition of G-protein-activated inwardly rectifying K+ channels by the selective norepinephrine reuptake inhibitors atomoxetine and reboxetine.
Neuropsychopharmacology, 2010 Jun , 35 (1560-9).

127

Rosenhouse-Dantsker A et al. Comparative analysis of cholesterol sensitivity of Kir channels: Role of the CD loop.
Channels (Austin), 2010 Jan 20 , 4 ().

128

Walsh KB A real-time screening assay for GIRK1/4 channel blockers.
J Biomol Screen, 2010 Dec , 15 (1229-37).

129

Balana B et al. Mutagenesis and functional analysis of ion channels heterologously expressed in Mammalian cells.
J Vis Exp, 2010 , ().

130

Holmegard HN et al. Genetic variation in the inwardly rectifying K channel subunits KCNJ3 (GIRK1) and KCNJ5 (GIRK4) in patients with sinus node dysfunction.
Cardiology, 2010 , 115 (176-81).

131

Ishihara K et al. Heteromeric assembly of inward rectifier channel subunit Kir2.1 with Kir3.1 and with Kir3.4.
Biochem. Biophys. Res. Commun., 2009 Mar 20 , 380 (832-7).

132

Swartz MF et al. Left versus right atrial difference in dominant frequency, K(+) channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery.
, 2009 Jun 17 , ().

133

Park HJ et al. Role of SREBP-1 in the development of parasympathetic dysfunction in the hearts of type 1 diabetic Akita mice.
Circ. Res., 2009 Jul 31 , 105 (287-94).

134

Liu X et al. Silencing GIRK4 expression in human atrial myocytes by adenovirus-delivered small hairpin RNA.
Mol. Biol. Rep., 2009 Jul , 36 (1345-52).

135

Gaborit N et al. Transcriptional profiling of ion channel genes in Brugada syndrome and other right ventricular arrhythmogenic diseases.
Eur. Heart J., 2009 Feb , 30 (487-96).

136

Zhang C et al. The single nucleotide polymorphisms of Kir3.4 gene and their correlation with lone paroxysmal atrial fibrillation in Chinese Han population.
Heart Lung Circ, 2009 Aug , 18 (257-61).

137

Robitaille M et al. Intracellular trafficking and assembly of specific Kir3 channel/G protein complexes.
Cell. Signal., 2009 Apr , 21 (488-501).

138

Hong CM et al. Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo.
Cardiology, 2009 , 112 (180-7).

139

Geng X et al. Specificity of Gbetagamma signaling depends on Galpha subunit coupling with G-protein-sensitive K(+) channels.
Pharmacology, 2009 , 84 (82-90).

140

Jin T et al. Stoichiometry of Kir channels with phosphatidylinositol bisphosphate.
Channels (Austin), 2008 Jan-Feb , 2 (19-33).

141

Yang D et al. Expression of inwardly rectifying potassium channel subunits in native human retinal pigment epithelium.
Exp. Eye Res., 2008 Sep , 87 (176-83).

142

Zhao Z et al. Molecular basis for genistein-induced inhibition of Kir2.3 currents.
Pflugers Arch., 2008 May , 456 (413-23).

143

Grasser E et al. Subunit stoichiometry of heterologously expressed G-protein activated inwardly rectifying potassium channels analysed by fluorescence intensity ratio measurement.
Pflugers Arch., 2008 Mar , 455 (1017-24).

144

Perry CA et al. Predisposition to late-onset obesity in GIRK4 knockout mice.
Proc. Natl. Acad. Sci. U.S.A., 2008 Jun 10 , 105 (8148-53).

145

Voigt N et al. Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes.
Cardiovasc. Res., 2008 Jan , 77 (35-43).

146

Ehrlich JR Inward rectifier potassium currents as a target for atrial fibrillation therapy.
J. Cardiovasc. Pharmacol., 2008 Aug , 52 (129-35).

147

Aguado C et al. Cell type-specific subunit composition of G protein-gated potassium channels in the cerebellum.
J. Neurochem., 2008 Apr , 105 (497-511).

148

Thomas AM et al. Determination of phosphoinositide binding to K(+) channel subunits using a protein-lipid overlay assay.
Methods Mol. Biol., 2008 , 491 (103-11).

149

Rosenhouse-Dantsker A et al. Potassium channel gating in the absence of the highly conserved glycine of the inner transmembrane helix.
Channels (Austin), 2007 May-Jun , 1 (189-97).

150

Lopes CM et al. Protein kinase A modulates PLC-dependent regulation and PIP2-sensitivity of K+ channels.
Channels (Austin), 2007 Mar-Apr , 1 (124-34).

151

Mintert E et al. Generation of a constitutive Na+-dependent inward-rectifier current in rat adult atrial myocytes by overexpression of Kir3.4.
J. Physiol. (Lond.), 2007 Nov 15 , 585 (3-13).

152

Eulitz D et al. Heterogeneous distribution of kir3 potassium channel proteins within dopaminergic neurons in the mesencephalon of the rat brain.
Cell. Mol. Neurobiol., 2007 May , 27 (285-302).

153

Liu B et al. Selective inhibition of Kir currents by antihistamines.
Eur. J. Pharmacol., 2007 Mar 8 , 558 (21-6).

154

Kobayashi T et al. Inhibition by cocaine of G protein-activated inwardly rectifying K+ channels expressed in Xenopus oocytes.
Toxicol In Vitro, 2007 Jun , 21 (656-64).

155

Calloe K et al. Characterizations of a loss-of-function mutation in the Kir3.4 channel subunit.
Biochem. Biophys. Res. Commun., 2007 Dec 28 , 364 (889-95).

156

Fowler CE et al. Evidence for association of GABA(B) receptors with Kir3 channels and regulators of G protein signalling (RGS4) proteins.
J. Physiol. (Lond.), 2007 Apr 1 , 580 (51-65).

157

Kawano T et al. Interaction of Galphaq and Kir3, G protein-coupled inwardly rectifying potassium channels.
Mol. Pharmacol., 2007 Apr , 71 (1179-84).

158

Steinecker B et al. The GIRK1 brain variant GIRK1d and its functional impact on heteromultimeric GIRK channels.
J. Recept. Signal Transduct. Res., 2007 , 27 (369-82).

159

Kobayashi T et al. Inhibition of G protein-activated inwardly rectifying K+ channels by the antidepressant paroxetine.
J. Pharmacol. Sci., 2006 Nov , 102 (278-87).

160

Iwasaki YK et al. A method for the simultaneous analysis of mRNA levels of multiple cardiac ion channels with a multi-probe RNase protection assay.
, 2006 Nov , 8 (1011-5).

161

Thomas AM et al. Differential phosphoinositide binding to components of the G protein-gated K+ channel.
J. Membr. Biol., 2006 May , 211 (43-53).

162

Kobayashi T et al. Inhibition of G protein-activated inwardly rectifying K+ channels by ifenprodil.
Neuropsychopharmacology, 2006 Mar , 31 (516-24).

163

Makary SM et al. Base of pore loop is important for rectification, activation, permeation, and block of Kir3.1/Kir3.4.
Biophys. J., 2006 Jun 1 , 90 (4018-34).

164

Pondugula SR et al. Glucocorticoid regulation of genes in the amiloride-sensitive sodium transport pathway by semicircular canal duct epithelium of neonatal rat.
Physiol. Genomics, 2006 Jan 12 , 24 (114-23).

165

Chen X et al. Inhibition of a background potassium channel by Gq protein alpha-subunits.
Proc. Natl. Acad. Sci. U.S.A., 2006 Feb 28 , 103 (3422-7).

166

Dhar MS et al. Protein expression of G-protein inwardly rectifying potassium channels (GIRK) in breast cancer cells.
BMC Physiol., 2006 , 6 (8).

167

Rapedius M et al. Long chain CoA esters as competitive antagonists of phosphatidylinositol 4,5-bisphosphate activation in Kir channels.
J. Biol. Chem., 2005 Sep 2 , 280 (30760-7).

168

Kanjhan R et al. Tertiapin-Q blocks recombinant and native large conductance K+ channels in a use-dependent manner.
J. Pharmacol. Exp. Ther., 2005 Sep , 314 (1353-61).

169

Makary SM et al. A difference in inward rectification and polyamine block and permeation between the Kir2.1 and Kir3.1/Kir3.4 K+ channels.
J. Physiol. (Lond.), 2005 Nov 1 , 568 (749-66).

170

Sarac R et al. Mutation of critical GIRK subunit residues disrupts N- and C-termini association and channel function.
J. Neurosci., 2005 Feb 16 , 25 (1836-46).

171

Pertovaara A et al. RFamide-related peptides signal through the neuropeptide FF receptor and regulate pain-related responses in the rat.
Neuroscience, 2005 , 134 (1023-32).

172

Shankar H et al. Role of G protein-gated inwardly rectifying potassium channels in P2Y12 receptor-mediated platelet functional responses.
Blood, 2004 Sep 1 , 104 (1335-43).

173

Ennion SJ et al. Identification of the P2Y(12) receptor in nucleotide inhibition of exocytosis from bovine chromaffin cells.
Mol. Pharmacol., 2004 Sep , 66 (601-11).

174

Claydon TW et al. K+ activation of kir3.1/kir3.4 and kv1.4 K+ channels is regulated by extracellular charges.
Biophys. J., 2004 Oct , 87 (2407-18).

175

Kobayashi T et al. Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs.
Neuropsychopharmacology, 2004 Oct , 29 (1841-51).

176

Fleischmann BK et al. Differential subunit composition of the G protein-activated inward-rectifier potassium channel during cardiac development.
J. Clin. Invest., 2004 Oct , 114 (994-1001).

177

Nikolov EN et al. Functional characterization of a small conductance GIRK channel in rat atrial cells.
Biophys. J., 2004 Nov , 87 (3122-36).

178

Nikolov EN et al. Coordination of membrane excitability through a GIRK1 signaling complex in the atria.
J. Biol. Chem., 2004 May 28 , 279 (23630-6).

179

Mirshahi T et al. Molecular determinants responsible for differential cellular distribution of G protein-gated inwardly rectifying K+ channels.
J. Biol. Chem., 2004 Mar 19 , 279 (11890-7).

180

Kawano T et al. Single-cell RT-PCR analysis of GIRK channels expressed in rat locus coeruleus and nucleus basalis neurons.
Neurosci. Lett., 2004 Mar 18 , 358 (63-7).

181

Mao J et al. Molecular basis for the inhibition of G protein-coupled inward rectifier K(+) channels by protein kinase C.
Proc. Natl. Acad. Sci. U.S.A., 2004 Jan 27 , 101 (1087-92).

182

Zhang L et al. Mechanosensitivity of GIRK channels is mediated by protein kinase C-dependent channel-phosphatidylinositol 4,5-bisphosphate interaction.
J. Biol. Chem., 2004 Feb 20 , 279 (7037-47).

183

Plummer HK et al. Expression of inwardly rectifying potassium channels (GIRKs) and beta-adrenergic regulation of breast cancer cell lines.
BMC Cancer, 2004 Dec 16 , 4 (93).

184

Wellner-Kienitz MC et al. Voltage dependence of ATP-dependent K+ current in rat cardiac myocytes is affected by IK1 and IK(ACh).
J. Physiol. (Lond.), 2004 Dec 1 , 561 (459-69).

185

Bender K et al. Acute desensitization of GIRK current in rat atrial myocytes is related to K+ current flow.
J. Physiol. (Lond.), 2004 Dec 1 , 561 (471-83).

186

Ramu Y et al. Short variable sequence acquired in evolution enables selective inhibition of various inward-rectifier K+ channels.
Biochemistry, 2004 Aug 24 , 43 (10701-9).

187

Sarmast F et al. Cholinergic atrial fibrillation: I(K,ACh) gradients determine unequal left/right atrial frequencies and rotor dynamics.
Cardiovasc. Res., 2003 Oct 1 , 59 (863-73).

188

Cader ZM et al. Significant linkage to migraine with aura on chromosome 11q24.
Hum. Mol. Genet., 2003 Oct 1 , 12 (2511-7).

189

Kobayashi T et al. Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac).
Br. J. Pharmacol., 2003 Mar , 138 (1119-28).

190

Mao J et al. Inhibition of G-protein-coupled inward rectifying K+ channels by intracellular acidosis.
J. Biol. Chem., 2003 Feb 28 , 278 (7091-8).

191

Müllner C et al. Single channel analysis of the regulation of GIRK1/GIRK4 channels by protein phosphorylation.
Biophys. J., 2003 Feb , 84 (1399-409).

192

Dibb KM et al. Molecular basis of ion selectivity, block, and rectification of the inward rectifier Kir3.1/Kir3.4 K(+) channel.
J. Biol. Chem., 2003 Dec 5 , 278 (49537-48).

193

Claydon TW et al. The selectivity filter may act as the agonist-activated gate in the G protein-activated Kir3.1/Kir3.4 K+ channel.
J. Biol. Chem., 2003 Dec 12 , 278 (50654-63).

194

Bosche LI et al. G protein-independent inhibition of GIRK current by adenosine in rat atrial myocytes overexpressing A1 receptors after adenovirus-mediated gene transfer.
J. Physiol. (Lond.), 2003 Aug 1 , 550 (707-17).

195

Ippolito DL et al. N-terminal tyrosine residues within the potassium channel Kir3 modulate GTPase activity of Galphai.
J. Biol. Chem., 2002 Sep 6 , 277 (32692-6).

196

Mao J et al. Molecular determinants for activation of G-protein-coupled inward rectifier K+ (GIRK) channels by extracellular acidosis.
J. Biol. Chem., 2002 Nov 29 , 277 (46166-71).

197

Mirshahi T et al. Gbeta residues that do not interact with Galpha underlie agonist-independent activity of K+ channels.
J. Biol. Chem., 2002 Mar 1 , 277 (7348-55).

198

Raap M et al. Diversity of Kir channel subunit mRNA expressed by retinal glial cells of the guinea-pig.
Neuroreport, 2002 Jun 12 , 13 (1037-40).

199

Kobayashi T et al. Functional characterization of an endogenous Xenopus oocyte adenosine receptor.
Br. J. Pharmacol., 2002 Jan , 135 (313-22).

200

Wickman K et al. Structural characterization of the mouse Girk genes.
Gene, 2002 Feb 6 , 284 (241-50).

201

Ma D et al. Diverse trafficking patterns due to multiple traffic motifs in G protein-activated inwardly rectifying potassium channels from brain and heart.
Neuron, 2002 Feb 28 , 33 (715-29).

202

He C et al. Identification of critical residues controlling G protein-gated inwardly rectifying K(+) channel activity through interactions with the beta gamma subunits of G proteins.
J. Biol. Chem., 2002 Feb 22 , 277 (6088-96).

203

Marker CL et al. Hyperalgesia and blunted morphine analgesia in G protein-gated potassium channel subunit knockout mice.
Neuroreport, 2002 Dec 20 , 13 (2509-13).

204

Bettahi I et al. Contribution of the Kir3.1 subunit to the muscarinic-gated atrial potassium channel IKACh.
J. Biol. Chem., 2002 Dec 13 , 277 (48282-8).

205

Dobrzynski H et al. Effects of ACh and adenosine mediated by Kir3.1 and Kir3.4 on ferret ventricular cells.
Am. J. Physiol. Heart Circ. Physiol., 2002 Aug , 283 (H615-30).

206

Choi S et al. Functional expression of a novel ginsenoside Rf binding protein from rat brain mRNA in Xenopus laevis oocytes.
Mol. Pharmacol., 2002 Apr , 61 (928-35).

207

Dobrzynski H et al. Distribution of the muscarinic K+ channel proteins Kir3.1 and Kir3.4 in the ventricle, atrium, and sinoatrial node of heart.
J. Histochem. Cytochem., 2001 Oct , 49 (1221-34).

208

Dobrev D et al. Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action potentials.
Circulation, 2001 Nov 20 , 104 (2551-7).

209

Rogalski SL et al. Eicosanoids inhibit the G-protein-gated inwardly rectifying potassium channel (Kir3) at the Na+/PIP2 gating site.
J. Biol. Chem., 2001 May 4 , 276 (14855-60).

210

Brundel BJ et al. Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels.
J. Am. Coll. Cardiol., 2001 Mar 1 , 37 (926-32).

211

Shui Z et al. Evidence of involvement of GIRK1/GIRK4 in long-term desensitization of cardiac muscarinic K+ channels.
Am. J. Physiol. Heart Circ. Physiol., 2001 Jun , 280 (H2554-62).

212

Gregerson KA et al. Identification of G protein-coupled, inward rectifier potassium channel gene products from the rat anterior pituitary gland.
Endocrinology, 2001 Jul , 142 (2820-32).

213

Hill JJ et al. Inhibition of a Gi-activated potassium channel (GIRK1/4) by the Gq-coupled m1 muscarinic acetylcholine receptor.
J. Biol. Chem., 2001 Feb 23 , 276 (5505-10).

214

Ruiz-Velasco V et al. Functional expression and FRET analysis of green fluorescent proteins fused to G-protein subunits in rat sympathetic neurons.
J. Physiol. (Lond.), 2001 Dec 15 , 537 (679-92).

215

Bender K et al. Overexpression of monomeric and multimeric GIRK4 subunits in rat atrial myocytes removes fast desensitization and reduces inward rectification of muscarinic K(+) current (I(K(ACh))). Evidence for functional homomeric GIRK4 channels.
J. Biol. Chem., 2001 Aug 3 , 276 (28873-80).

216

Inanobe A et al. Interaction between the RGS domain of RGS4 with G protein alpha subunits mediates the voltage-dependent relaxation of the G protein-gated potassium channel.
J. Physiol. (Lond.), 2001 Aug 15 , 535 (133-43).

217

Weigl LG et al. G protein-gated inwardly rectifying potassium channels are targets for volatile anesthetics.
Mol. Pharmacol., 2001 Aug , 60 (282-9).

218

Corey S et al. The Stoichiometry of Gbeta gamma binding to G-protein-regulated inwardly rectifying K+ channels (GIRKs).
J. Biol. Chem., 2001 Apr 6 , 276 (11409-13).

219

Pabon A et al. Glycosylation of GIRK1 at Asn119 and ROMK1 at Asn117 has different consequences in potassium channel function.
J. Biol. Chem., 2000 Sep 29 , 275 (30677-82).

220

Medina I et al. A switch mechanism for G beta gamma activation of I(KACh).
J. Biol. Chem., 2000 Sep 22 , 275 (29709-16).

221

Dibb KM et al. Cs+ block of the cardiac muscarinic K+ channel, GIRK1/GIRK4, is not dependent on the aspartate residue at position 173.
Pflugers Arch., 2000 Sep , 440 (740-4).

222

Mark MD et al. G-protein mediated gating of inward-rectifier K+ channels.
Eur. J. Biochem., 2000 Oct , 267 (5830-6).

223

Lancaster MK et al. Residues and mechanisms for slow activation and Ba2+ block of the cardiac muscarinic K+ channel, Kir3.1/Kir3.4.
J. Biol. Chem., 2000 Nov 17 , 275 (35831-9).

224

Bard J et al. Single channel studies of inward rectifier potassium channel regulation by muscarinic acetylcholine receptors.
J. Gen. Physiol., 2000 Nov , 116 (645-52).

225

Yakubovich D et al. Slow modal gating of single G protein-activated K+ channels expressed in Xenopus oocytes.
J. Physiol. (Lond.), 2000 May 1 , 524 Pt 3 (737-55).

226

Müllner C et al. Heterologous facilitation of G protein-activated K(+) channels by beta-adrenergic stimulation via cAMP-dependent protein kinase.
J. Gen. Physiol., 2000 May , 115 (547-58).

227

Wulfsen I et al. Expression of mRNA for voltage-dependent and inward-rectifying K channels in GH3/B6 cells and rat pituitary.
J. Neuroendocrinol., 2000 Mar , 12 (263-72).

228

Ivanina T et al. Expression of GIRK (Kir3.1/Kir3.4) channels in mouse fibroblast cells with and without beta1 integrins.
FEBS Lett., 2000 Jan 28 , 466 (327-32).

229

Nehring RB et al. Neuronal inwardly rectifying K(+) channels differentially couple to PDZ proteins of the PSD-95/SAP90 family.
J. Neurosci., 2000 Jan 1 , 20 (156-62).

230

Bradley KK et al. Kir3.1/3.2 encodes an I(KACh)-like current in gastrointestinal myocytes.
Am. J. Physiol. Gastrointest. Liver Physiol., 2000 Feb , 278 (G289-96).

231

Lohberger B et al. IK.ACh activation by arachidonic acid occurs via a G-protein-independent pathway mediated by the GIRK1 subunit.
Pflugers Arch., 2000 Dec , 441 (251-6).

232

Rogalski SL et al. TrkB activation by brain-derived neurotrophic factor inhibits the G protein-gated inward rectifier Kir3 by tyrosine phosphorylation of the channel.
J. Biol. Chem., 2000 Aug 18 , 275 (25082-8).

233

Lei Q et al. Activation and inhibition of G protein-coupled inwardly rectifying potassium (Kir3) channels by G protein beta gamma subunits.
Proc. Natl. Acad. Sci. U.S.A., 2000 Aug 15 , 97 (9771-6).

234

Wickman K et al. Brain localization and behavioral impact of the G-protein-gated K+ channel subunit GIRK4.
J. Neurosci., 2000 Aug 1 , 20 (5608-15).

235

Kobayashi T et al. Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K(+) (GIRK) channels expressed in xenopus oocytes.
Br. J. Pharmacol., 2000 Apr , 129 (1716-22).

236

Crossen PE et al. Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomes.
Cancer Genet. Cytogenet., 1999 Sep , 113 (126-33).

237

McAllister SD et al. Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in a xenopus oocyte expression system.
J. Pharmacol. Exp. Ther., 1999 Nov , 291 (618-26).

238

Jelacic TM et al. Functional expression and characterization of G-protein-gated inwardly rectifying K+ channels containing GIRK3.
J. Membr. Biol., 1999 May 15 , 169 (123-9).

239

Jin W et al. Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization.
J. Neurosci., 1999 May 15 , 19 (3773-80).

240

Owen JM et al. Effect of extracellular cations on the inward rectifying K+ channels Kir2.1 and Kir3.1/Kir3.4.
Exp. Physiol., 1999 May , 84 (471-88).

241

Otero AS et al. Wild-type NM23-H1, but not its S120 mutants, suppresses desensitization of muscarinic potassium current.
Biochim. Biophys. Acta, 1999 Mar 8 , 1449 (157-68).

242

Morishige K et al. Secretagogue-induced exocytosis recruits G protein-gated K+ channels to plasma membrane in endocrine cells.
J. Biol. Chem., 1999 Mar 19 , 274 (7969-74).

243

Stevens EB et al. Bombesin receptors inhibit G protein-coupled inwardly rectifying K+ channels expressed in Xenopus oocytes through a protein kinase C-dependent pathway.
Mol. Pharmacol., 1999 Jun , 55 (1020-7).

244

Zhang H et al. Activation of inwardly rectifying K+ channels by distinct PtdIns(4,5)P2 interactions.
Nat. Cell Biol., 1999 Jul , 1 (183-8).

245

Kennedy ME et al. GIRK4 confers appropriate processing and cell surface localization to G-protein-gated potassium channels.
J. Biol. Chem., 1999 Jan 22 , 274 (2571-82).

246

Yoshimoto Y et al. Somatostatin induces hyperpolarization in pancreatic islet alpha cells by activating a G protein-gated K+ channel.
FEBS Lett., 1999 Feb 12 , 444 (265-9).

247

Rohács T et al. Distinct specificities of inwardly rectifying K(+) channels for phosphoinositides.
J. Biol. Chem., 1999 Dec 17 , 274 (36065-72).

248

He C et al. Identification of a potassium channel site that interacts with G protein betagamma subunits to mediate agonist-induced signaling.
J. Biol. Chem., 1999 Apr 30 , 274 (12517-24).

249

Ho BY et al. Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channels.
Recept. Channels, 1999 , 6 (363-74).

250

Smith KE et al. Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels.
J. Biol. Chem., 1998 Sep 4 , 273 (23321-6).

251

Silverman SK et al. Asymmetrical contributions of subunit pore regions to ion selectivity in an inward rectifier K+ channel.
Biophys. J., 1998 Sep , 75 (1330-9).

252

Corey S et al. Identification of native atrial G-protein-regulated inwardly rectifying K+ (GIRK4) channel homomultimers.
J. Biol. Chem., 1998 Oct 16 , 273 (27499-504).

253

Kovoor A et al. Agonist induced homologous desensitization of mu-opioid receptors mediated by G protein-coupled receptor kinases is dependent on agonist efficacy.
Mol. Pharmacol., 1998 Oct , 54 (704-11).

254

Krapivinsky G et al. Gbeta binding to GIRK4 subunit is critical for G protein-gated K+ channel activation.
J. Biol. Chem., 1998 Jul 3 , 273 (16946-52).

255

Ji S et al. Mechanosensitivity of the cardiac muscarinic potassium channel. A novel property conferred by Kir3.4 subunit.
J. Biol. Chem., 1998 Jan 16 , 273 (1324-8).

256

Wickman K et al. Abnormal heart rate regulation in GIRK4 knockout mice.
Neuron, 1998 Jan , 20 (103-14).

257

Corey S et al. Number and stoichiometry of subunits in the native atrial G-protein-gated K+ channel, IKACh.
J. Biol. Chem., 1998 Feb 27 , 273 (5271-8).

258

McPhee JC et al. Evidence for a functional interaction between integrins and G protein-activated inward rectifier K+ channels.
J. Biol. Chem., 1998 Dec 25 , 273 (34696-702).

259

Murer G et al. An immunocytochemical study on the distribution of two G-protein-gated inward rectifier potassium channels (GIRK2 and GIRK4) in the adult rat brain.
Neuroscience, 1997 Sep , 80 (345-57).

260

Kovoor A et al. Mu and delta opioid receptors are differentially desensitized by the coexpression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in xenopus oocytes.
J. Biol. Chem., 1997 Oct 31 , 272 (27605-11).

261

Thomas SL et al. Tissue-specific regulation of G-protein-coupled inwardly rectifying K+ channel expression by muscarinic receptor activation in ovo.
J. Biol. Chem., 1997 Nov 21 , 272 (29958-62).

262

Luchian T et al. A C-terminal peptide of the GIRK1 subunit directly blocks the G protein-activated K+ channel (GIRK) expressed in Xenopus oocytes.
J. Physiol. (Lond.), 1997 Nov 15 , 505 ( Pt 1) (13-22).

263

Chan KW et al. Specific regions of heteromeric subunits involved in enhancement of G protein-gated K+ channel activity.
J. Biol. Chem., 1997 Mar 7 , 272 (6548-55).

264

Wickman K et al. Partial structure, chromosome localization, and expression of the mouse Girk4 gene.
Genomics, 1997 Mar 15 , 40 (395-401).

265

Ehrengruber MU et al. Activation of heteromeric G protein-gated inward rectifier K+ channels overexpressed by adenovirus gene transfer inhibits the excitability of hippocampal neurons.
Proc. Natl. Acad. Sci. U.S.A., 1997 Jun 24 , 94 (7070-5).

266

Kim D et al. ATP-dependent regulation of a G protein-coupled K+ channel (GIRK1/GIRK4) expressed in oocytes.
Am. J. Physiol., 1997 Jan , 272 (H195-206).

267

Schoots O et al. Genomic organization and promoter analysis of the human G-protein-coupled K+ channel Kir3.1 (KCNJ3/HGIRK1).
Genomics, 1997 Feb 1 , 39 (279-88).

268

Vivaudou M et al. Probing the G-protein regulation of GIRK1 and GIRK4, the two subunits of the KACh channel, using functional homomeric mutants.
J. Biol. Chem., 1997 Dec 12 , 272 (31553-60).

269

Huang CL et al. Binding of the G protein betagamma subunit to multiple regions of G protein-gated inward-rectifying K+ channels.
FEBS Lett., 1997 Apr 1 , 405 (291-8).

270

Wischmeyer E et al. Subunit interactions in the assembly of neuronal Kir3.0 inwardly rectifying K+ channels.
Mol. Cell. Neurosci., 1997 , 9 (194-206).

271

Karschin C et al. Ontogeny of gene expression of Kir channel subunits in the rat.
Mol. Cell. Neurosci., 1997 , 10 (131-48).

272

McKinnon LA et al. Regulation of muscarinic receptor expression and function in cultured cells and in knock-out mice.
Life Sci., 1997 , 60 (1101-4).

273

Lagrutta AA et al. Inward rectifier potassium channels. Cloning, expression and structure-function studies.
, 1996 Sep , 37 (651-60).

274

Matthes H et al. Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes.
Mol. Pharmacol., 1996 Sep , 50 (447-50).

275

Saugstad JA et al. Metabotropic glutamate receptors activate G-protein-coupled inwardly rectifying potassium channels in Xenopus oocytes.
J. Neurosci., 1996 Oct 1 , 16 (5979-85).

276

Silverman SK et al. Subunit stoichiometry of a heteromultimeric G protein-coupled inward-rectifier K+ channel.
J. Biol. Chem., 1996 Nov 29 , 271 (30524-8).

277

Chan KW et al. Control of channel activity through a unique amino acid residue of a G protein-gated inwardly rectifying K+ channel subunit.
Proc. Natl. Acad. Sci. U.S.A., 1996 Nov 26 , 93 (14193-8).

278

Sui JL et al. Na+ activation of the muscarinic K+ channel by a G-protein-independent mechanism.
J. Gen. Physiol., 1996 Nov , 108 (381-91).

279

Chan KW et al. A recombinant inwardly rectifying potassium channel coupled to GTP-binding proteins.
J. Gen. Physiol., 1996 Mar , 107 (381-97).

280

Rimland JM et al. Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y.
Mol. Pharmacol., 1996 Mar , 49 (387-90).

281

Karschin C et al. IRK(1-3) and GIRK(1-4) inwardly rectifying K+ channel mRNAs are differentially expressed in the adult rat brain.
J. Neurosci., 1996 Jun 1 , 16 (3559-70).

282

Spauschus A et al. A G-protein-activated inwardly rectifying K+ channel (GIRK4) from human hippocampus associates with other GIRK channels.
J. Neurosci., 1996 Feb 1 , 16 (930-8).

283

Silverman SK et al. A regenerative link in the ionic fluxes through the weaver potassium channel underlies the pathophysiology of the mutation.
Proc. Natl. Acad. Sci. U.S.A., 1996 Dec 24 , 93 (15429-34).

284

Doupnik CA et al. Time resolved kinetics of direct G beta 1 gamma 2 interactions with the carboxyl terminus of Kir3.4 inward rectifier K+ channel subunits.
Neuropharmacology, 1996 , 35 (923-31).

285

Duprat F et al. Heterologous multimeric assembly is essential for K+ channel activity of neuronal and cardiac G-protein-activated inward rectifiers.
Biochem. Biophys. Res. Commun., 1995 Jul 17 , 212 (657-63).

286

Tucker SJ et al. Assignment of KATP-1, the cardiac ATP-sensitive potassium channel gene (KCNJ5), to human chromosome 11q24.
Genomics, 1995 Jul 1 , 28 (127-8).